Type 2 Diabetes

Women with endometriosis had an overall 46% higher risk of developing Type 2 diabetes. The association was strongest among premenopausal women and women without obesity, groups not traditionally considered high-risk for Type 2 diabetes.

A University of Pennsylvania study found that GLP-1 users with Type 2 diabetes had 37% to 68% higher hair loss rates than patients taking other diabetes medications.

Mounjaro is now approved for two indications: to improve blood sugar in patients with Type 2 diabetes and to lower the major adverse cardiovascular events.

University of Maryland researchers used machine learning models trained on claims data of adults with diabetes to predict monthly risk of nine acute and chronic complications.

Awiqli is the first once-weekly basal insulin for Type 2 diabetes. It has a list price of $99 a package and is also available for a $35 copay for eligible patients.

New research in Menopause shows diabetic women face greater symptom burden during menopause transition, suggesting diabetes care should incorporate menopause symptom assessment and management.

A study by the American Diabetes Association also finds that 1.5 million diabetic Medicaid enrollees face new cost-sharing by 2029, potentially adding $1,000 in annual out-of-pocket costs in some states.

An analysis at Montefiore Medical Center in New York finds that expanding CGM implementation in primary care improves diabetes outcomes and reduce acute care utilization, particularly in underserved populations.

Despite similar diabetes technology use among the minority patients surveyed, Black patients showed higher A1C than White non-Hispanic patients, with insurance access and cost as the biggest barriers to using insulin pumps or connected insulin pens.

An American Diabetes Association survey has found that high insulin costs are straining patients financially, with 1 in 3 cutting groceries. A new Senate bill aims to limit copays and boost PBM rebate transparency.

The approach of pairing an ecological framework with AI methods offers a new way to identify where diabetes risk concentrates.

An electronic health record–based diabetes risk tool helped primary care teams target prevention and reduce progression to type 2 diabetes in prediabetes patients.

An electronic health record–based model could help health systems target diabetes prevention to the high-risk patients most likely to benefit.

The award will involve patients with chronic disease and their families to inform clinical research, with an initial focus on diabetes.

David Hines examines the profound impact of social determinants like food insecurity, housing instability, and limited access to healthcare services on the health outcomes of individuals with diabetes, while also delving into the multifaceted barriers hindering effective diabetes management and offering insights to overcome these challenges.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, discusses socioeconomic barriers, such as financial constraints, unstable housing, stressful living situations, and demanding work schedules, can hinder diabetes self-care, requiring healthcare providers to approach patients with empathy when addressing these challenges.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCC, discusses how technological advancements in diabetes care, such as continuous glucose monitors, can help patients better manage their disease.

Estay Greene, PharmD, MBA, offers key takeaways and provides closing thoughts on remaining unmet needs in the treatment of patients with diabetes.

Insights on how payers can allocate their resources to best improve outcomes for patients with diabetes.

Payer perspectives on the challenges and advantages of integrating continuous glucose monitoring into diabetes management programs, highlighting the navigation of prior authorization requirements.

A new study finds that the use of continuous glucose monitoring helps reduce complications from type 1 diabetes, lowering the risk of developing or progressing diabetic retinopathy.